1. Catalog
  2. Patient-Centered Urine Drug Testing: Facts you Sho ...
Image For Activity Cover
Patient-Centered Urine Drug Testing: Facts you Should Know!
Description
Drug testing is an important tool in the management of all patients on chronic opioid therapy or who are being treated for opioid use disorder. This module will review best clinical practices for the use and management of UDT in outpatient practice.
Target Audience
Physicians
Presenters
J. Deanna Wilson, MD, MPH, University of Pittsburgh School of Medicine, Board Certified in Addiction Medicine, Assistant Professor of Medicine and Pediatrics and Howard A. Heit, MD, FACP, FASAM, Diplomate in Addiction Medicine’ Chronic Pain Specialist, Certified as a Medical Review Officer, Assistant Clinical Professor, Georgetown University
Objectives

At the conclusion of this activity participants should be able to:

  • Discuss testing methodology in urine drug testing (UDT)
  • Differentiate between qualitative vs. quantitative UDT
  • Review drug metabolism for common opioids
  • Recommend “best clinical practices” for the use and management of UDT in outpatient practice
Method of participation in the activity

To be awarded a maximum of 1 AMA PRA Category 1 Credits™ you must:

1.  Review 1 training module (1 hour) provided in this activity. 
2.  Earn a minimum cumulative score of 70% on the examination. 
3.  Complete a final evaluation and follow instructions at the end of the course regarding how to retrieve your Certificate of Completion as well as a CME Credit Certificate*.

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.

Summary
Availability:
Retired
Cost:
FREE
Credit Offered:
No Credit Offered
Create Account
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.


Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org
Powered By